advancing innovation to save lives

A Pipeline of Promise: The Global Health Research and Development Process

Check out our interactive infographic to learn more about the global health R&D process and challenges that arise along the development pipeline.
Learn More

R&D Facts

Be in the know. Discover important facts and figures about global health research and development on our R&D Facts page.
Learn More

Infectious Diseases Society of America

IDSA’s blog Science Speaks offers the latest news and analysis on global infectious disease policy, science, research, and development.  Click to read Science Speaks’ analysis of the 115th Congress and the Presidential transition.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Rose Slavkovsky
GenomeWeb reports on GHTC advocacy for an essential diagnostics list

GenomeWeb reports on GHTC's call to World Health Organization to establish an essential diagnostics list, quoting GHTC policy officer Matt Robinson.

PDF
GHTC sends letter urging WHO to establish an essential diagnostics list

GHTC sent a letter to the World Health Organization's (WHO) Assistant Director-General of  Health Systems and Innovation urging WHO to support the establishment of an essential diagnostics list.

PDF
View All News & Events

Member Event

PATH/Doune Porter
Community Discussion on the Reinstatement of the Mexico City Policy
Global Health Council
Learn More

Member Event

Global Health Council
The Future of Global Health 2017
Global Health Council
Learn More
View All Events
PATH/Gabe Bienczycki
Research Roundup: Spillover and spillback, 3D spheres for drug development, drug resistance, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
GHTC/Matt Robinson
WHO Executive Board meeting closes with three shortlisted candidates to lead WHO and R&D issues added to WHA agenda

The 140th session of the World Health Organization (WHO) Executive Board (EB) closed last week with a shortlist of  three candidates for the WHO Director General position and progress on key global health R&D issues.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide